Marcus Hjort
Teaching assistant at Department of Medical Cell Biology; Education
- Visiting address:
- BMC
Husargatan 3
751 23 Uppsala - Postal address:
- Box 571
751 23 UPPSALA
Download contact information for Marcus Hjort at Department of Medical Cell Biology; Education
More information is available to staff who log in.
Publications
Selection of publications
- Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries (2019)
- Interphysician agreement on subclassification of myocardial infarction. (2018)
- Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries (2018)
- Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice (2015)
- Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells (2015)
Recent publications
- Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries (2023)
- Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function. (2023)
- Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease (2023)
- Identification of pathophysiological and prognostic biomarkers in different types of myocardial infarction (2022)
- GRACE 2.0 Score for Risk Prediction in Myocardial Infarction With Nonobstructive Coronary Arteries (2021)
All publications
Articles
- Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries (2023)
- Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function. (2023)
- Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease (2023)
- GRACE 2.0 Score for Risk Prediction in Myocardial Infarction With Nonobstructive Coronary Arteries (2021)
- Clinical and prognostic implications of C-reactive protein levels in myocardial infarction with nonobstructive coronary arteries (2021)
- Sex-differences in circulating biomarkers during acute myocardial infarction (2021)
- Predicting outcome in acute myocardial infarction (2021)
- Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction (2021)
- Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries (2019)
- Diagnosing type 2 myocardial infarction in clinical routine. A validation study (2019)
- Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries (2019)
- Interphysician agreement on subclassification of myocardial infarction. (2018)
- Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries (2018)
- Concomitant analysis of Helios and Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice (2015)
- Interleukin-35 administration counteracts established murine type 1 diabetes - possible involvement of regulatory T cells (2015)